Introduction
The importance of transferrin and iron for cell growth is well illustrated by the observation that proliferating cells in vitro have an absolute requirement for transferrin [l] . Although transferrin binds iron with a very high association constant (-lo2' 121) cells are able to remove the iron and incorporate it into functional and storage compounds without degradation of the carrier protein.
After removal of the iron, transferrin is released from cells and its unoccupied iron-binding sites become available to bind iron. Most of this comes from erythrocytes destroyed in the reticuloendothelial system. Smaller amounts of iron are released into the plasma by the gut mucosa, after absorption of food iron, and by the liver, where a depot of iron exists. Some of the cellular aspects of this cycle of iron exchange with transferrin have been studied using erythroid cells and in particular the reticulocyte. More recently, with the advent of techniques for the isolation and culture of non-erythroid mammalian cells it is becoming apparent that many of the underlying mechanisms in iron exchange are common to all cells. To utilize transferrin iron cells must express a plasma membrane receptor for the protein which allows the binding and uptake of transferrin and its passenger iron. The physical and chemical properties of this receptor, isolated from a variety of cells and tissues, have been studied.
Characterization of the transferrin receptor
The molecular characteristics of the transferrin receptor, isolated from the rabbit reticulocyte membrane, were first reported by Aisen and colleagues [3, identical subunits, and, in common with other membrane receptors, contains carbohydrate residues. The dimensions of the receptor-transferrin complex in solution, 4 n m x 3 6 n m [4] , indicate that the receptor could easily span the cell membrane. Similar characteristics have been reported for the human transferrin receptor isolated from placenta [5] and more recently from human leukaemia cells [6, suggests that a 70000 daltons fragment of the receptor is exposed on the cell surface whereas a 5000 daltons region is accessible at the interior of the membrane, leaving a region of approximately 15 000 daltons spanning the membrane.
Expression of transferrin receptors
Tumour cell-lines, which grow rapidly in culture, have the receptor at all stages of growth, but the receptor density may vary with the growth phase of the cell [12, 131. In contrast, the reticulocyte rapidly loses its ability to bind transferrin as it matures to an erythrocyte [12, 141 and the peripheral blood lymphocyte only begins to synthesize the receptor after mitogen stimulation [13, 15,161.
Quantification of the receptors expressed by whole cells usually employs a functional assay of the binding of radiolabelled transferrin to cells at temperatures between 4°C and 37°C. At the lower temperatures two-to three-fold less transferrin is bound by cells than at physiological temperatures [17-191. The likely cause of this disparity is that transferrin bound to the surface receptor at 37°C is internalized by the cell, as judged by its inaccessibility to exogenous proteases [ 10, 171 and to acid cleavage from the receptor [17, 191, whereas at 4°C the protein remains on the surface of the cell and is thus fully accessible. Klausner et al. [19] have demonstrated that about twothirds of the total complement of transferrin receptors are inside the cell and Hamilton [20] has confirmed that this internal pool of receptors exchanges with the surface receptors during the uptake and release of transferrin. Since this distribution of receptors is the same as found for cell-associated transferrin at 37"C, it is probable that transferrin and its receptor remain associated during the endocytic cycle. Recently, direct evidence that this is the case has come from a preliminary report by Harding et al. [21] , in which gold-labelled transferrin was observed to remain closely associated with the membrane of intracellular vesicles after uptake by cells.
The reported association constants for the binding of transferrin to cells are somewhat variable but fall within the range from 2 x lo7 l/mol t o 2 x 10' l/mol, depending on the temperature and conditions used [ [18] reported that receptor expression in cultured human fibroblasts bore a reciprocal relationship to the amount of inorganic iron added t o the medium.
In developing erythroid cells [25] transferrin and iron uptake are closely parallel regardless of the maturity of the cells. This is probably because, owing to the high demand for iron by these haemoglobin synthesizing cells, most of the iron is stripped from the transferrin taken up. However, in cultured cells this close coupling of transferrin and iron uptake appears t o break down. These cells bind as much transferrin as erythroid cells but take up iron at very low rates [12, 16, 171. Faulk et al. [26] suggested that transformed and malignant cells may bind large amounts of transferrin to disguise surface antigens rather than expressing the receptors to facilitate iron uptake. However, this now seems unlikely in view of more recent evidence that transferrin is endocytosed after binding to its receptor and would, therefore, be unavailable for antigen disguise on the cell surface. Furthermore, others [6, 7, 151 have found that probably all proliferating cells, including transformed lymphocytes, express transferrin receptors and that their growth has an absolute requirement for transferrin and iron in the culture medium [l] . Taken together these findings suggest that the receptors on these cells function, as they do on normal cells, to allow the uptake of iron. During infection, malignancy and inflammation serum iron falls to low levels [27] and it is under these conditions that lymphoid cells must be activated by noxious stimuli and respond by proliferating. It is possible that the enhanced expression of transferrin receptors by transformed lymphocytes enables them to grow unchecked by the prevailing iron-deficient environment. Similarly, the ability of malignant cells to proliferate under these conditions may be facilitated by their expression of large numbers of functional transferrin receptors.
Iron uptake and utilization
It appears that iron delivery to cells, at normal plasma iron saturations, will be dominated by diferric transferrin since the magnitude of the association constant for the binding of diferric transferrin to its receptor is sufficiently high to give almost complete saturation of transferrin receptors in vivo, given the usual concentration of diferric transferrin in human plasma (-4 pmol/l). Monoferric transferrins bind with a lower association constant (S. P. Young & A. Bomford, unpublished observation), which helps to explain why, although cells are able to remove the single iron atom from monoferric transferrin, it is only one-seventh as effective an iron donor as diferric transferrin when they are in competition [28] . At pH 7.4 and 37°C apotransferrin binds to the receptor with an apparent association constant (in the rat) only one-thirtieth of that of diferric transferrin [29] . Thus, even though much of plasma transferrin is in the iron-free form, it should not interfere with the process of iron uptake by cells.
Reticulocytes Morgan has proposed this as evidence for the involvement of lysosomes in the release of iron to the cell, since transferrin binds iron only weakly at the pH of lysosomes. The acid environment of these organelles could easily facilitate the release of iron from the protein. However, little transferrin is degraded during the process of iron delivery [ 17,431, even though it is known that the protein is susceptible to proteolysis in lysosomes [43] . With some other endocytotic processes, such as the uptake of asialoglycoproteins by hepatocytes, it is apparent that the ligand passes through a pre-lysosomal, acidic compartment in which the low pH facilitates the cleavage of the ligand/receptor complex [44] , thereby allowing the recycling of the unoccupied receptor to the cell surface and routing of the ligand to the lysosomes. It is known that transferrin, unlike many other ligands, remains associated with its receptor at low pH [5] and it has recently been proposed [45, 461 that it is this property which allows transferrin to escape transfer to the lysosomes. By remaining associated with its receptor transferrin is recycled to the exterior of the cell in an undegraded form. Furthermore, apotransferrin also adheres to the receptor at low pH and, if iron is removed from transferrin during its passage through the acidified vesicle, the iron-free protein would similarly escape routing to the lysosomes and be released from the cell.
Given this proposed mechanism for iron release from internalized transferrin, it might be expected that only apotransferrin would be released from the cells if all of the vesicular iron was transferred to the cell. However, it has been shown that transferrin can be released from cells carrying some iron [30, 471. These observations suggest that the locus for the control of iron uptake by cells may be at the point at which iron is removed from internalized transferrin, rather than at the plasma membrane. As discussed earlier different cell types express different numbers of transferrin receptors, as do cultured cells at various phases in their growth cycle [12] and, although the locus for the control of iron uptake is probably intracellular, an element of control, perhaps longer term, may thus be exerted at the cell membrane by modulation of receptor numbers.
Once iron is released from transferrin the metal must be transferred to the sites of utilization. In the reticulocyte the major destination for the iron is haemoglobin, but in other cells the proportion used for haem synthesis is much less. In Chang cells [48] approximately 60% of the iron taken up from transferrin is found in ferritin, whereas in phytohaemagglu tinin-stimulated human lymphocytes, incubated with transferrin for a short time (3 h), 35% was found in ferritin, only 5% in haem and the remainder in an undefined fraction (A.
Bomford & S. P. Young, unpublished observation).
A proportion of the last-named may represent the socalled labile or easily chelatable iron pool [49] . The role proposed for this pool is to act both as a precursor which is incorporated into functional complexes [SO] and as the immediate source of iron for release from cells [Sl]. It is known that inorganic iron compounds may be utilized by isolated mitochondria for haem synthesis and it is possible that the free pool of iron is the immediate source of iron for mitochondria inside the cell [52] . However, Ulvik & Romslo [53] have shown that ferritin iron can also be mobilized by isolated mitochondria for haem synthesis and this form of iron has been suggested as an obligatory intermediate for haem synthesis in reticulocytes [54] . This suggestion is contradicted by recent results from Egyed [SS], who showed that iron incorporated into ferritin by reticulocytes was not subsequently used for haemoglobin synthesis. Furthermore he identified several non-haem/nonferritin complexes within this cell which could be potential sources of iron for the mitochondria. The chemistry of iron probably precludes the existence of free ionic forms of the metal under physiological conditions, and its propensity to form complexes with many intracellular proteins and low molecular weight compounds may explain why many putative intermediates in the transport of iron have been found. It remains to be seen which of these complexes are of physiological importance.
Iron release from cells
After donation of its iron, transferrin is released from the cell and is then available for many more plasma-to-cell cycles, as is indicated by its long plasma half-life (7-10 days) compared with its passenger iron (1.5-2 h) [56] . The protein then acquires more of the metal for another transport cycle to occur and most of this comes from the cells of the reticuloendothelial system, after erythrocyte breakdown. Iron seems to be released from these cells in vivo by a process which leads to random binding of the iron to any available vacant transferrin iron-binding site, both on monoferric transferrin and apotransferrin [57] . Since diferric transferrin is a better iron donor in vitro than monoferric transferrin [28] it is likely that, in vivo, transferrin must acquire two atoms of iron before it becomes an effective iron donor. Iron released from isolated rat hepatocytes also binds randomly to any empty iron-binding sites on transferrin [30] . The absence of specific receptors for apotransferrin on hepatocytes suggests that the iron-free protein acts as a passive acceptor of iron released from these cells [29], a conclusion also reached by others using the intact perfused rat liver [58] . Recently, however, it has been reported that there are specific receptors for apotransferrin on stimulated rat peritoneal macrophages [ 591, but it remains to be shown that the binding of apotransferrin to these receptors is a prerequisite for the release of iron.
Iron is also released to transferrin from gut mucosal cells and it has been reported that apotransferrin may bind to these cells more avidly than does iron-transferrin [60] . If this is the case then the levels of apotransferrin in the plasma could have a role in regulating iron absorption. It is even possible to speculate that it is the extent of the hepatic iron store that controls absorption indirectly through its established influence on the rate of synthesis of transferrin [61] and thus serum transferrin concentrations. However, Wheby & Jones [62] showed that, in vivo, the complete saturation of circulating transferrin with iron failed to diminish transfer of iron from the mucosa to the plasma, which suggests that, even if apotransferrin does bind to these cells, it is not an obligatory step during the absorption of iron. Clinical evidence in patients with hereditary haemochromatosis shows that before treatment, when serum transferrin is fully saturated and body iron stores are increased, iron absorption is within the normal range [63] . Venesection therapy, to deplete the iron stores, leads to increased rates of absorption even when transferrin saturation remains high. Thus the iron status of the serum transferrin is unlikely to be the sole factor controlling iron absorption. Cavil1 ef al. [64] , in an attempt to explain the reasons for the complex nature of the control process, have proposed that, rather than the iron saturation of transferrin, it is the rate of plasma iron turnover which controls absorption.
The cellular interactions with transferrin discussed in this review are the basis of wholebody iron exchange. In vivo, iron flux is quantitatively dominated by the movement of iron from the reticuloendothelial system to the erythroid bone marrow. However, since all growing cells must take up iron from transferrin the exchange with non-erythroid tissues is important in maintaining normal tissue function. The importance of non-erythroid iron exchange is illustrated by the preferential maintenance of tissue iron levels in the face of the profound fall in circulating haemoglobin seen in iron-deficiency anaemia [65] . The mechanism by which t h s protection of nonerythroid cells occurs is not known but the cellular mechanisms described in this review, such as the dependence of transferrin receptor expression on iron availability, may play a pdrt. U.S.A., 78, 4515 
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